Pliant Therapeutics, Inc. - stock earnings
PLRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.1 million USD | 4.8 million USD |
| 2023Q3 | -41.5 million USD | ? USD |
| 2023Q2 | -41.2 million USD | 248000 USD |
| 2023Q1 | -28.1 million USD | 1.3 million USD |
| 2022Q4 | -34.6 million USD | 2.0 million USD |
| 2022Q3 | -28.0 million USD | 1.5 million USD |
| 2022Q2 | -29.4 million USD | 5.0 million USD |
| 2022Q1 | -27.9 million USD | 1.2 million USD |
| 2021Q4 | -24.5 million USD | 2.0 million USD |
| 2021Q3 | -27.0 million USD | 1.6 million USD |
| 2021Q2 | -22.8 million USD | 1.8 million USD |
| 2021Q1 | -22.9 million USD | 2.2 million USD |
| 2020Q4 | -19.0 million USD | 4.5 million USD |
| 2020Q3 | -16.5 million USD | 4.8 million USD |
| 2020Q2 | -17.0 million USD | 3.6 million USD |
| 2020Q1 | 11.0 million USD | 28.9 million USD |
| 2019Q4 | 42.2 million USD | 57.1 million USD |
| 2019Q3 | -13.3 million USD | ? USD |
| 2019Q2 | -15.5 million USD | ? USD |
| 2019Q1 | -14.0 million USD | ? USD |
PLRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -161.3 million USD | 1.6 million USD |
| 2022 | -121.5 million USD | 9.7 million USD |
| 2021 | -17.9 million USD | 7.6 million USD |
| 2020 | -39.7 million USD | 41.8 million USD |
| 2019 | 185000 USD | 57.1 million USD |
| 2018 | -30.3 million USD | ? USD |
| 2017 | -18.3 million USD | ? USD |
PLRX
Price: $12.28
52 week price:
Earnings Per Share: -2.75 USD
P/E Ratio: -5.74
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 852.4 million